UMHS logo

RETURN TO PRESS RELEASE PAGE  
link - UMHS HOME link UMHS HOME

January 6, 2003

U-M study takes a closer look at polio's lifelong effects

Study focuses on gender differences, menopause impact as polio survivors grow older

Contact information for:
JOURNALISTS & MEDIA


Information for:
PATIENTS, FAMILIES & HEALTH PROFESSIONALS




NEW
Radio news


Current UMHS News Releases

Past UMHS Releases

UMHS in the media

U-M main campus news


 

ANN ARBOR, MI - Polio, a disease that has the potential to paralyze and even kill its victims, was once prevalent in the United States before a vaccine was made available to the public in 1955. And with no new cases of polio reported in the U.S. for more than 20 years, the only reminder of this past epidemic are its survivors - a group, like many others with disabilities, that is now living longer than ever before.

But despite the growth in this segment of this population, very little is still known about how the effects of aging, and especially menopause, impacts polio survivors' quality of life.

Now researchers in the University of Michigan Health System's Rehabilitation Psychology and Neuropsychology Division of the Department of Physical Medicine and Rehabilitation will take a closer look at the menopausal experience of women polio survivors, including an extensive study of aspects of both male and female survivors' current health.

The study, "Women with Polio: Menopause, Late Effects, Quality of Life, and Psychological Well Being," is funded through a $25,000 award from the Gazette International Networking Institute's (GINI) Post-Poliomyelitis Research Grant.

As its name suggests, the study will explore the relationships between menopause, late effects, hormone replacement therapy risks, life satisfaction and emotional distress in the overall quality of survivors' lives.

Past evidence has found that women with a history of polio may have a greater prevalence of late effect symptoms like pain, fatigue and weakness after the age of 50. However, it is not known whether or not those symptoms are influenced by menopause, says Claire Z. Kalpakjian, Ph.D., project manager and co-investigator.

"For women survivors, developing pain and fatigue about 30 years after having polio typically coincides with menopause," she explains. "What we hope to uncover is the influence menopause, if there even is one, has on polio survivors' pre-existing conditions and whether pre-existing conditions such as fatigue and pain make the menopausal transition harder for some women."

To find out more, a group of 800 to 900 women with a history of polio, the majority of whom will be middle-aged, will be recruited from the International Polio Network. The Network will also help recruit 800 to 900 men from the same age group with a history of polio. The balance of men and women subjects in this study is important since most polio studies tend to report on a greater number of females. Both groups will complete a mailed survey questionnaire.

For the menopause component of the study, the men will serve as the control group to allow researchers to compare the differences between men and women. This will show the impact, if any, that menopause has on female polio survivors.

This comparison between genders will also allow for an in-depth exploration of differences between men and women in terms of late effects of polio and other health problems they may be experiencing.

"As we learn and understand more about how men and women polio survivors differ as they age, we'll be able to help identify the best treatment and health management approaches for both groups," says Kalpakjian.

Other members of the U-M research team include: Principal investigator Denise G. Tate, Ph.D., professor, Department of Physical Medicine and Rehabilitation; co-investigator Elisabeth H. Quint, M.D., associate professor, U-M Department of Obstetrics and Gynecology; and polio survivor and project consultant Sunny Roller, MS, Department of Physical Medicine and Rehabilitation.

To learn more about polio research and treatment at the U-M Health System, call (734) 936 7052.

Facts about polio

  • Polio is an orally contracted virus. Some cases do not cause serious illness, however other cases may lead to paralysis or even death.
  • In 1916, a polio epidemic began in the United States that killed 6,000 Americans and paralyzed 27,000 others annually. By the early 1950s, more than 20,000 cases of polio were reported each year. Once the polio vaccine became available to the public in 1955, the cases of the disease began to drop. By 1979, there were only 10 cases reported in the country. However, the disease is still common in other parts of the world.
  • Today, polio survivors are one of the largest disabilities groups in the U.S. A 1987 survey conducted by the National Center for Health Statistics found that 1.6 million Americans had contracted and survived polio. About 640,000 of those cases resulted in paralytic polio, which increased the risk for post-polio syndrome.
  • Post-polio syndrome occurs about 10 to 40 years after the initial onset of polio. It can cause fatigue, muscle weakness, joint pain and muscular atrophy. The severity of post-polio depends on how serious the polio attack was initially.

Written by Krista Hopson

 

E-mail this information to a friend


Recent Press Releases


U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright 2008 Regents of the University of Michigan
Developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 U.S. News and World Reports: America's Best Hospitals 2006
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index